Cargando…

Discovery of a mammalian FASN inhibitor against xenografts of non-small cell lung cancer and melanoma

Detalles Bibliográficos
Autores principales:	Cao, Danfeng, Yang, Jie, Deng, Youchao, Su, Meng, Wang, Yeji, Feng, Xueqiong, Xiong, Yi, Bai, Enhe, Duan, Yanwen, Huang, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402528/ https://www.ncbi.nlm.nih.gov/pubmed/36002450 http://dx.doi.org/10.1038/s41392-022-01099-4

Ejemplares similares

Identification of Acetylation Sites of Fatty Acid Synthase (FASN) by Mass Spectrometry and FASN Activity Assay
por: Miao, Ting, et al.
Publicado: (2023)

Deregulated FASN Expression in BRAF Inhibitor-Resistant Melanoma Cells Unveils New Targets for Drug Combinations
por: Stamatakos, Serena, et al.
Publicado: (2021)

Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth
por: Han, Anna, et al.
Publicado: (2023)

Icaritin, a novel FASN inhibitor, exerts anti-melanoma activities through IGF-1R/STAT3 signaling
por: Wu, Jinfeng, et al.
Publicado: (2016)

The fasn-1(g14ts) allele is a Gly1830Arg missense mutation in C. elegans FASN-1
por: Bai, Xiaofei, et al.
Publicado: (2020)

Targeting FASN in Breast Cancer and the Discovery of Promising Inhibitors from Natural Products Derived from Traditional Chinese Medicine
por: Cheng, Chien-shan, et al.
Publicado: (2014)

FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression
por: Heuer, Timothy S., et al.
Publicado: (2016)

A FASN-TGF-β1-FASN regulatory loop contributes to high EMT/metastatic potential of cisplatin-resistant non-small cell lung cancer
por: Yang, Li, et al.
Publicado: (2016)

Discovery of small molecule Gαq/11 protein inhibitors against uveal melanoma
por: Ge, Yang, et al.
Publicado: (2022)

FASN inhibitor TVB-3166 prevents S-acylation of the spike protein of human coronaviruses
por: Mekhail, Katrina, et al.
Publicado: (2022)

Metformin alleviates inflammation through suppressing FASN-dependent palmitoylation of Akt
por: Xiong, Wenfang, et al.
Publicado: (2021)

Comprehensive Analysis of FASN in Tumor Immune Infiltration and Prognostic Value for Immunotherapy and Promoter DNA Methylation
por: Zhang, Mingyang, et al.
Publicado: (2022)

FASN activity is important for the initial stages of the induction of senescence
por: Fafián-Labora, Juan, et al.
Publicado: (2019)

Modulation of Breast Cancer Cell FASN Expression by Obesity-Related Systemic Factors
por: McClellan, Bryan, et al.
Publicado: (2022)

Discovery of a potent and dual-selective bisubstrate inhibitor for protein arginine methyltransferase 4/5
por: Al-Hamashi, Ayad A., et al.
Publicado: (2021)

MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression
por: Duan, Jiangman, et al.
Publicado: (2017)

MAPK/P53-mediated FASN expression in bone tumors
por: Jiang, Ye, et al.
Publicado: (2017)

Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma
por: Sun, Tianhao, et al.
Publicado: (2019)

FASN-dependent de novo lipogenesis is required for brain development
por: Gonzalez-Bohorquez, Daniel, et al.
Publicado: (2022)

Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
por: Yin, Jie, et al.
Publicado: (2023)

FASN-Mediated Lipid Metabolism Regulates Goose Granulosa Cells Apoptosis and Steroidogenesis
por: Chen, Xi, et al.
Publicado: (2020)

Fatty Acid Synthase Inhibitor Platensimycin Intervenes the Development of Nonalcoholic Fatty Liver Disease in a Mouse Model
por: Su, Meng, et al.
Publicado: (2021)

The Deubiquitinase USP13 Maintains Cancer Cell Stemness by Promoting FASN Stability in Small Cell Lung Cancer
por: Wang, Juhong, et al.
Publicado: (2022)

FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer
por: Cao, Zhi, et al.
Publicado: (2020)

Integrated Transcriptome and Metabolome Analysis Reveals the Regulatory Mechanisms of FASN in Geese Granulosa Cells
por: Chen, Xi, et al.
Publicado: (2022)

FASN expression, angiogenesis and lymphangiogenesis in central and peripheral giant cell lesions
por: FALCI, Saulo Gabriel Moreira, et al.
Publicado: (2014)

Fasnall Induces Atypically Transient Stress Granules Independently of FASN Inhibition
por: Amen, Triana, et al.
Publicado: (2020)

FASN Is a Biomarker Enriched in Malignant Glioma-Derived Extracellular Vesicles
por: Ricklefs, Franz L., et al.
Publicado: (2020)

Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells
por: Schroeder, Barbara, et al.
Publicado: (2021)

SREBP1/FASN/cholesterol axis facilitates radioresistance in colorectal cancer
por: Jin, Yuxiao, et al.
Publicado: (2021)

Concomitant Inhibition of FASN and SREBP Provides a Promising Therapy for CTCL
por: Chi, Cheng, et al.
Publicado: (2022)

Small molecule inhibitors of mammalian glycosylation
por: Almahayni, Karim, et al.
Publicado: (2022)

Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis
por: Han, Zelong, et al.
Publicado: (2022)

Transient perfusion in human melanoma xenografts.
por: Tufto, I., et al.
Publicado: (1995)

Pig fatness in relation to FASN and INSIG2 genes polymorphism and their transcript level
por: Grzes, Maria, et al.
Publicado: (2016)

The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
por: Winarno, G. N. A., et al.
Publicado: (2020)

Reducing FASN expression sensitizes acute myeloid leukemia cells to differentiation therapy
por: Humbert, Magali, et al.
Publicado: (2021)

FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma
por: Chianese, Ugo, et al.
Publicado: (2023)

The Application of Patient-Derived Xenograft Models in Gynecologic Cancers
por: Jiang, Wenxiao, et al.
Publicado: (2020)

Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer
por: Grunt, Thomas W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0lqgt6j7vst7spuljbou3r2983